Meropenem Trihydrate: Broad-Spectrum Carbapenem Antibiotic for Antibacterial Research

Executive Summary: Meropenem trihydrate is a broad-spectrum β-lactam antibiotic exhibiting low MIC₉₀ values (≤0.12–1 mg/L) against key gram-negative and gram-positive pathogens, including Escherichia coli and Klebsiella pneumoniae (Dixon et al., 2025). It acts by inhibiting bacterial cell wall synthesis via penicillin-binding protein targeting. Its efficacy is modulated by pH, showing enhanced activity at physiological pH 7.5 compared to acidic pH 5.5. Meropenem trihydrate is stable in aqueous solution for short durations at ≤-20°C and is highly soluble in water and DMSO, but insoluble in ethanol. APExBIO supplies Meropenem trihydrate (SKU B1217) for scientific research use only, supporting reproducible workflows in resistance and infection model studies (product page).

Biological Rationale

Carbapenem antibiotics are considered last-resort agents in the treatment of multidrug-resistant bacterial infections, notably those caused by Enterobacterales (Dixon et al., 2025). The rise of carbapenemase-producing Enterobacterales (CPE) has driven demand for molecular and phenotypic research tools to understand resistance mechanisms. Meropenem trihydrate's broad antibacterial spectrum includes activity against both gram-negative and gram-positive bacteria, as well as anaerobes. It is widely used as a reference standard in comparative susceptibility and resistance studies (GentamycinSulfate.com). This product's low MIC₉₀ values and β-lactamase stability underpin its utility in laboratory benchmarking and translational microbiology (P005091.com).

Mechanism of Action of Meropenem trihydrate

Meropenem trihydrate exerts its antibacterial effect by binding to penicillin-binding proteins (PBPs) in bacterial cell walls, thereby inhibiting the final transpeptidation step of peptidoglycan synthesis (Dixon et al., 2025). This leads to cell lysis and bacterial death. The trihydrate form is highly soluble in water (≥20.7 mg/mL at 37°C) and DMSO (≥49.2 mg/mL), promoting ease of preparation for in vitro and in vivo research applications (APExBIO). Its activity is optimal at physiological pH (7.5) and decreases in acidic conditions (pH 5.5), a property relevant for model system design. Meropenem is stable to most β-lactamases, including extended-spectrum β-lactamases (ESBLs), but is hydrolyzed by carbapenemases, which are the primary mechanism of resistance in CPE (Dixon et al., 2025).

Evidence & Benchmarks

• Meropenem trihydrate demonstrates MIC₉₀ values ≤0.12–1 mg/L against E. coli, K. pneumoniae, and Streptococcus pneumoniae under standard aerobic conditions (Dixon et al., 2025, DOI).
• Carbapenem resistance in Enterobacterales primarily results from carbapenemase enzyme production, efflux pump activity, and porin mutations, with enzyme-mediated hydrolysis being dominant (Dixon et al., 2025, DOI).
• In acute necrotizing pancreatitis rat models, meropenem trihydrate reduced pancreatic infection, hemorrhage, and fat necrosis; these effects were enhanced when co-administered with deferoxamine (APExBIO, product page).
• Metabolomics-based LC-MS/MS profiling can distinguish CPE from non-CPE isolates within 7 hours, supporting rapid resistance phenotyping using meropenem as a probe antibiotic (Dixon et al., 2025, DOI).
• Meropenem trihydrate is supplied as a solid, is insoluble in ethanol, and must be stored at -20°C; aqueous solutions are recommended for short-term use only (APExBIO, product page).

This article extends prior coverage by emphasizing quantitative, metabolomics-driven benchmarks for resistance phenotyping, updating and clarifying scope compared to this review (which focuses on clinical isolates and MICs), and this systems biology analysis (which details mechanisms but not workflow integration).

Applications, Limits & Misconceptions

Meropenem trihydrate is a reference compound for research on resistance phenotyping, antibacterial mechanism studies, and infection model validation. It is used extensively in LC-MS/MS-based metabolomics to profile resistance biomarkers and cellular responses (Dixon et al., 2025). In vivo, it supports models of acute necrotizing pancreatitis and co-therapy optimization. However, the compound is not intended for clinical diagnostic or therapeutic use (APExBIO).

Common Pitfalls or Misconceptions

• Meropenem trihydrate is not effective against carbapenemase-producing Enterobacterales due to enzymatic hydrolysis (Dixon et al., 2025).
• It is not suitable for long-term solution storage; use freshly prepared solutions for reproducibility (APExBIO).
• The compound is not a substitute for clinical-grade antibiotics and must not be used in human or veterinary medicine.
• Antibacterial activity is reduced at acidic pH (5.5); experimental conditions must reflect physiological relevance.
• It is insoluble in ethanol—incorrect solvent selection can result in failed experiments.

Workflow Integration & Parameters

Meropenem trihydrate (SKU B1217) from APExBIO is formulated as a solid for research use. Recommended storage is -20°C, protected from light and moisture. For solution preparation, dissolve in sterile water (≥20.7 mg/mL at 37°C) or DMSO (≥49.2 mg/mL), avoiding ethanol. Use freshly prepared solutions within experimental protocols to ensure stability and activity. In resistance phenotyping, typical assays include MIC determination, time-kill kinetics, and LC-MS/MS-based metabolomic profiling. For best practices and scenario-based guidance, see this workflow primer; this article expands upon solution chemistry details and resistance model integration.

Conclusion & Outlook

Meropenem trihydrate remains a gold-standard research tool in antibacterial and resistance studies, particularly for gram-negative and gram-positive pathogens. Its low MIC₉₀ values, broad-spectrum efficacy, and documented in vivo performance make it indispensable for molecular mechanism and systems biology research. Ongoing advances in metabolomics and rapid phenotyping will further leverage Meropenem trihydrate's role as a benchmark antibiotic in resistance and infection model research. For detailed specifications and ordering, visit the APExBIO product page.